UBS O'Connor’s enVVeno Medical NVNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $962K | Sell |
241,161
-54,870
| -19% | -$219K | 0.05% | 208 |
|
|
2025
Q1 | $779K | Hold |
296,031
| – | – | 0.02% | 191 |
|
|
2024
Q4 | $894K | Hold |
296,031
| – | – | 0.02% | 234 |
|
|
2024
Q3 | $995K | Buy |
296,031
+65,241
| +28% | +$219K | 0.02% | 272 |
|
|
2024
Q2 | $1.21M | Buy |
230,790
+4,482
| +2% | +$23.5K | 0.03% | 269 |
|
|
2024
Q1 | $1.23M | Sell |
226,308
-10,000
| -4% | -$54.4K | 0.04% | 252 |
|
|
2023
Q4 | $1.21M | Buy |
236,308
+10,000
| +4% | +$51.4K | 0.04% | 245 |
|
|
2023
Q3 | $1.22M | Buy |
226,308
+39,494
| +21% | +$213K | 0.02% | 303 |
|
|
2023
Q2 | $575K | Buy |
186,814
+9,204
| +5% | +$28.3K | 0.01% | 426 |
|
|
2023
Q1 | $840K | Buy |
+177,610
| New | +$840K | 0.02% | 421 |
|
|
2022
Q4 | – | Sell |
-149,720
| Closed | -$940K | – | 212 |
|
|
2022
Q3 | $940K | Buy |
149,720
+31,607
| +27% | +$198K | 0.01% | 740 |
|
|
2022
Q2 | $446K | Buy |
+118,113
| New | +$446K | ﹤0.01% | 801 |
|